OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 51-75 of 91 citing articles:

Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives
María Paula Ceballos, Ariel D. Quiroga, Nicolás Francisco Palma
Biochemical Pharmacology (2023) Vol. 212, pp. 115573-115573
Closed Access | Times Cited: 6

Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses
Gang Cheng, Jing Pan, Radosław Podsiadły, et al.
Free Radical Biology and Medicine (2019) Vol. 147, pp. 167-174
Open Access | Times Cited: 19

Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients
Hui Zheng, Meiqin Zhang, Shuang Ma, et al.
Cancer Medicine (2020) Vol. 9, Iss. 14, pp. 5200-5209
Open Access | Times Cited: 15

Advances in DNA Repair—Emerging Players in the Arena of Eukaryotic DNA Repair
Mateusz Kciuk, Karol Bukowski, Beata Marciniak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3934-3934
Open Access | Times Cited: 15

SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma
Kavita Bhalla, Sausan Jaber, Kayla Reagan, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 15

Bioinformatic Analysis of the Effect of the Sirtuin Family on Differentiated Thyroid Carcinoma
Yao Li-jun, Yinhua Wang
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 9

LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway
Wenjing Shi, Liqun Ling, Changhong Li, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 3, pp. 1295-1311
Closed Access | Times Cited: 9

GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A20
Souren Paul, Monika Bhardwaj, Sun Chul Kang
International Journal of Oncology (2022) Vol. 61, Iss. 5
Open Access | Times Cited: 9

Nicotinamide Mononucleotide Prevents Cisplatin-Induced Mitochondrial Defects in Cortical Neurons Derived from Human Induced Pluripotent Stem Cells
Mohammad Abdur Rashid, Alfredo Oliveros, Yu Shin Kim, et al.
Brain Plasticity (2022) Vol. 8, Iss. 2, pp. 143-152
Open Access | Times Cited: 9

The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity
Tushar Ranjan Panda, M Manikandan, Shreyas P. Vaidya, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 38
Closed Access | Times Cited: 5

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
Fengyi Guo, Hongjing Wang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8

Pistachio Green Hull Extract Induces Apoptosis through Multiple Signaling Pathways by Causing Oxidative Stress on Colon Cancer Cells
İsmail Koyuncu, Ataman Gönel, Ebru Temiz, et al.
Anti-Cancer Agents in Medicinal Chemistry (2020) Vol. 21, Iss. 6, pp. 725-737
Closed Access | Times Cited: 12

The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells
Lei Sun, Wei-Xue Ji, Yan Li, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy
Ramia J. Salloom, Iman M. Ahmad, Dania Z. Sahtout, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9195-9195
Open Access | Times Cited: 1

SIRT5 participates in the suppressive tumor immune microenvironment of EGFR-mutant LUAD by regulating the succinylation of ACAT1
Wang Shouhan, Qingchang Li, Xiaodan Sun
Heliyon (2024) Vol. 10, Iss. 21, pp. e39743-e39743
Open Access | Times Cited: 1

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
Huihuan Wang, Juan Li, Rui Huang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 8

Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer
Francesca Paradiso, Stefania Lenna, Salvatore A. Gazzè, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 824-824
Open Access | Times Cited: 5

Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**
Nima Rajabi, Tobias Hansen, Alexander L. Nielsen, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 22
Open Access | Times Cited: 5

Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers
Lai Wen, Jianquan Chen, Tianming Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2

Design, synthesis and biological evaluation of 2,4,6- trisubstituted triazine derivatives as new nonpeptide small-molecule SIRT5 inhibitors
Lijiao Wang, Lei Hu, Jianlin Deng, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 93, pp. 117455-117455
Closed Access | Times Cited: 2

Knockdown of circLRWD1 weakens DDP resistance via reduction of SIRT5 expression through releasing miR-507 in non-small cell lung cancer
Zhongbiao Deng, Qimin Tu, Guoliang Hu, et al.
Anti-Cancer Drugs (2022)
Closed Access | Times Cited: 3

Scroll to top